Phototherapy home ultra violet UV treatment

This page contains phototherapy information from the media, you will find more information
on the menu to the left. The following are extracts of articles from scientific journals,
magazines and newspapers from around the world in which phototherapy ultraviolet light is
used as a treatment of a disease such as psoriasis, vitiligo, dermatitis and acne. For more
details about any of these articles please contact the relevant publisher directly.

Is UV in phototherapy Carcinogenic?

Ben Lebwohl, Harvard College, and John Y. M. Koo, M.D. University of California
phototherapy Ultraviolet light B, which is recognized as a carcinogen (a cancer-causing
agent) in sunlight, consists of wavelengths similar to those administered in UVB
phototherapy. Does UVB treatment increase one's risk of developing malignant melanoma or
other skin cancers?

"The answer appears to be no"

phototherapy studies performed over the last two decades have consistently shown that the
incidence of skin cancer in patients receiving UVB phototherapy is not increased above the
incidence in the general population. These findings include the investigation of UVB
treatment alone, in addition to UVB supplemented by another known carcinogen, topical coal
tar, in the Goeckerman regimen (a day-treatment program in which patients receive tar and
light treatments).

Goeckerman patients studied in one of the most comprehensive studies of this subject, Mark
pittelkow, M.D., and co-authors at the Mayo Clinic retrospectively reviewed 280 psoriasis
patients in a 25-year follow-up. All of the patients had been hospitalized and treated with
crude coal tar and ultraviolet light. The incidence of skin cancer in those patients was not
increased over the expected incidence.

In a second study of skin cancers in patients with atopic dermatitis who were treated with
Goeckerman regimen, Willard Maughan and co-authors completed a 25-year follow-up study
of 426 patients and again found no significant increase in the incidence of skin cancer.

Results surprising.

These results are surprising, considering the established carcinogenic properties of UVB light
found in natural sun light. Yet study after study has consistently proven that UVB treatment
does not pose as much risk as PUVA (psoralen plus ultraviolet light A).

At 1982 a study was set out to determine the carcinogenic risks of UVB by studying 85
psoriasis patients who had received more than 100 UVB treatments over a long period of
time. This population was compared to a control group with regard to precancerous and
cancerous skin lesions. While the percentage of these lesions in the control population was
10.1%. in the UVB-treated psoriasis patients it was 5.9%.
Because of studies such as these, some investigators at the time even suggested that patients
with psoriasis carried a lower risk of developing skin cancer, thought this has not proven to
be true, especially in light of the recent long-term PUVA study conducted by Robert Stern,
M.D., of Harvard Medical School (see "Long-term PUVA study emphasizes need for regular
skin examinations," May/June 1997 Bulletin Dr. Stern's investigation linking PUVA
treatments to squamous cell carcinoma also demonstrated that long-term UVB treatment
poses minimal risk of skin cancer except in male genitalia. It is because of this increased risk
male genitals are shielded during standard phototherapy treatment.

Sunburn is worse.

The surprisingly low carcinogenic risk associated with UVB phototherapy is not completely
understood, but can be explained in terms of low amounts of UVB dosage involved in typical
phototherapy.

Even an aggressive phototherapy regimen subjects patients to much lower UVB than a bad,
blistering sunburn. Moreover, it is possible that low dosage UVB treatments that are
gradually increased result in a thickening of the outermost layer of skin that might play a
protective role against skin cancer as it does in sunburn.

phototherapy units have very little output in the wavelength attributed to UVB-induced
cancer. It is possible that the ratio of therapeutic UVB to carcinogenic UVB is more
favourable in phototherapy units than in sunlight.

Saving face.

Finally, it is well known that psoriasis tends to spare the face. Therefore, it is common
practice in phototherapy to routinely shield the faces of patients with no facial lesions. Since
skin cancer risk is greatest on the face because of lifetime cumulative sun exposure, it is
possible that UVB to the parts of the body that are usually protected from sunlight such as the
elbows, knees, and lower back may never get the total exposure the face receives. This also
may account for the fact that no increase in skin cancer of any type has been attributed to
UVB for psoriasis.

UVB remains one of the safest effective psoriasis treatments currently available.

Units Treat psoriasis at Home. Australian Doctor Magazine June 2003. Home-use UVB
light units are a new option for patients with psoriasis who find regular hospital or
specialist clinic visits inconvenient. The narrow-band UVB units - some as small as a
hairdryer - can be bought or rented, saving patients from travelling long distances for
treatment at major centres.

Nick Balgowan, whose company supplies such units in Australia, said the problem with UV
treatment was that most patients needed it every day or 4-5 times a week, and even f the fee
for treatment in hospitals or specialist clinics was covered by Medicare, there was a
significant extra cost in terms of travel and time.

Leading dermatologist Dr Chris Baker, from Melbourne's St. Vincent's Hospital, said narrow-
band UVB treatment used only a fraction of the UVB spectrum, corresponding to the most
"biologically effective" wavelengths for treating psoriasis. Dr. Baker said this could reduce
the risk of side effects such as sunburn. UVB had the added advantage of not requiring
patients to take psoralen tablets (with known side effects,) unlike UVA phototherapy.

"The trend in recent years has been that narrow-band UVB is the first phototherapy that we
use," Dr Baker said. Mr Balgowan said the units, which were available globally from
www.beatpsoriasis.com come in a range of sizes.

psoriasis. An article in the August 1999 issue of The Chronicle of Skin Disease reports that it
takes fewer treatments to clear psoriasis vulgaris with Narrow Band UVB than it does with
conventional broadband UVB and that there is no statistically significant difference between
the two lamps regarding photo toxicity. These results were reported by Dr. Lori Hobbs,
clinical research fellow in Dermatology at Vancouver General Hospital, at the 74th annual
meeting of the Canadian Dermatology Association in Vancouver.

psoriasis. Dr. Adrian Tanew of the Division of Special and Environmental Dermatology at
the University of Vienna (Austria) found that Narrow Band UVB is nearly as effective as
PUVA in treating plaque-type psoriasis. Reported in the Archives of Dermatology
135[5]:519-24, 1999, he states, "Our data demonstrate that in many patients, in particular
those with moderate or moderate to severe psoriasis, narrow-band UVB is comparably as
effective as PUVA, whereas in the more severely affected, PUVA is superior."

psoriasis. Dr. Henry W. Lim, chairman of dermatology at the Henry Ford Hospital in Detroit
reported that "Narrow-band ultraviolet B light may carry no greater carcinogenic risk than
broad-band UVB when used to treat psoriasis." "Animal studies have determined that
narrow-band UVB is two to three times more carcinogenic per minimal erythemal dose
(MED) than its broad-band counterpart. When compared with broad-band UVB, however,
less MED-equivalents of narrow-band UVB are needed to clear psoriasis in humans." These
remarks were made at the annual colloquium on clinical dermatology (sponsored by the
Dermatology Foundation) and reported in the July 1998 issue of Skin & Allergy News.

psoriasis. photodermatol photoimmunol photomed: 1999:15:81-84 Charles L.G. Halasz,

Department of Dermatology, College of physicians & Surgeons of Columbia University, New
York, NY. "In summary, using a conservative fixed increment regimen, clearing of psoriasis
is possible while minimizing the risk of serious erythema. It is the author s opinion that,
compared to traditional broadband phototherapy, narrowband phototherapy leads to earlier
clinical improvement resulting in enhanced compliance with treatment and lower drop-out
rates."

psoriasis. Journal of the American Academy of Dermatology, 1999;40:893-900. In an article

entitled "Suberythemogenic narrow-band UVB is markedly more effective than conventional
UVB in treatment of psoriasis vulgaris", Dr. Ian B. Walters and others of the Laboratory for
Investigative Dermatology, The Rockefeller University, reported that eleven patients were
treated using a split-body approach for 6 weeks on a three-times-a week basis. Using
suberythemal doses of narrow-band UVB, they were able to induce clinical clearing in 81.8%
of patients after NB-UVB, but in only 9.1% of patients after BB-UVB. They concluded that
NB-UVB is superior to UVB-BB in reversing psoriasis at suberythemogenic doses when
given three times per week.

psoriasis. Archives of Dermatology, 1997;133:1514-1522. In an article entitled "Narrowband

UV-B produces Superior Clinical and Histopathological Resolution of Moderate-to Severe
psoriasis in patients Compared With Broadband UVB-B", Dr. Todd R. Coven and others of
the Laboratory for Investigative Dermatology, The Rockefeller University concluded "that
Narrowband UV-B offers a significant therapeutic advantage over BB UV-B in the treatment
of psoriasis, with faster clearing and more complete disease resolution. The erythemal
response to NB UV-B treatment was significantly more intense and persistent compared with
BB UV-B.

psoriasis. Skin and Allergy News, reporting from the annual meeting of the West Virginia
Dermatological Society, quoted Dr. Thomas Fitzpatrick, professor Emeritus of Dermatology
at Harvard University: "Bulbs that emit a narrow band of ultraviolet light in the UVB range
appear to be superior to traditional broad-band UVA for the treatment of psoriasis."

psoriasis. Journal of the American Academy of Dermatology 1997;36:577-81. D.A.R de

Berker and others report in an article entitled "Comparison of psoralen-UVB and psoralen-
UVA photochemotherapy in the treatment of psoriasis" that in a study of 100 patients with
plaque-type psoriasis, "no significant difference was found between the two treatments
[psoralen-UVB and psoralen-UVA] in the proportion of patients whose skin cleared during
treatment or in the number of exposures required for clearance of psoriasis." "Side effects and
disease status at 3 months after the end of treatment were similar for the two groups"

psoriasis. Skin and Allergy News, November 1997. Dr. Robert Rietschel, chairman of the
department of dermatology at Oschner Clinic in New Orleans, reported at the annual meeting
of the South Central Dermatological Congress, that "I've been very pleased with it [Narrow
Band UVB] and highly recommend it. It may be the only light source you'll need." The
article goes on to report that "Not only are the results as good with PUVA, but it obviates the
nausea and cost associated with oral psoralen. It does not carry the same risks of
photosensitivity, does not require eye protection except for during the treatment itself and
does not require ophthalmologic checkups. Pregnant women and children can be treated."

psoriasis. photodermatol photoimmunol photomed 1997: 13: 82-84. In an article entitled

"Narrow-band (311 nm) UVB phototherapy: an audit of the first year s experience at the
Massachusetts General Hospital" MBT Alora and CR Taylor, both from the phototherapy
Unit, Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA, state:
"In summary, published reports of controlled narrow-band studies have all shown superior
clinical results with minimal risk of burning. Our preliminary findings suggest that caution
must be exercised in using this modality, especially when patients miss treatments or the
irradiation protocols are aggressive. Careful attention to dosimetry is essential and patients
should be encouraged to express any, even minor symptoms, which may result from their last
treatment as we have seen a clear threshold phenomenon even with strict adherence to
standard protocols."

psoriasis, Scalp. Private communication written by Edmond I, Griffin, M.D. and others,
from Atlanta, Georgia, USA. " The Dermalight psora-Comb was used in a group of 13
patients with moderate to severe scalp psoriasis. Also included was 1 patient with chronic
persistent seborrhea. The group of 14 patients all received scalp phototherapy as part of an
intensive scalp therapy program." " In this group, the average treatment time at clearing was 9
minutes and 20 seconds. The average number of treatments needed to provide clearance was
20, with the highest being 32 and lowest being 10. Periods of remission were reported in the
group, with 57% experiencing remissions for 1-16 months, while the remaining 43% were
lost to follow up or discontinued treatment altogether." "In conclusion, we have found the
psora-Comb to be an effective instrument in our scalp therapy program, especially when used
with short contact anthralin therapy or psoralens either together or separately."

psoriasis, Scalp. G Ital Dermatol Venereol, 1989;124:LXI-LXV. In an article published in

Italy entitled "Fototerapia della psoriasis del cuoio capelluto" by Dr. M. Caccialanza and
others at the University of Milan, they state, "The presence of hair hampers the performance
of photo-and photochemotherapy and blocks the efficacy of exposure to sunlight in patients
affected by scalp psoriasis. A portable source of ultra-violet rays was tested on 21 patients:
the device is equipped with a special comb which, by separating the hair, partially overcomes
the protective shield formed by the latter." They further report that "A complete remission of
dermatosis was achieved in 6 cases, a marked improvement in 11 (50-95%), and a slight
improvement in 4 (20-30%). The source used was found to be efficacious especially in those
forms of slight to medium psoriasis of the capillitium; it was handy and easy to use making it
suitable for home use."

Atopic Dermatitis. The Skin and Allergy News, May 1999 reports that "Narrow-Band UVB
May Benefit Atopic Dermatitis." Dr. Craig A. Elmets of the University of Alabama at
Birmingham stated at the colloquium on clinical dermatology that "The single-frequency,
311-nm light source is nearly as effective as PUVA in atopic Dermatitis patients, with
potentially fewer side effects ??[but] still has an unproven safety record."

Atopic Dermatitis. The British Journal of Dermatology (1993) 128, 49-56 reported in an
article by Dr. S.A. George and others (photobiology Unit, Department of Dermatology,
Ninewells Hospital and Medical School, Dundee, UK.) that a 12 week course of Narrow
Band UVB resulted in a 68% reduction in atopic Dermatitis severity scores. The article
concluded that "Narrow-band UVB (TL-01) phototherapy appears an effective, steroid-
sparing treatment for chronic severe atopic Dermatitis, offering long-term benefits in the
majority of those treated."

Mycosis Fungoides. An article in Skin and Allergy News reported on a presentation by Dr.
Jane J. Kim of the Henry Ford Health System (Detroit) that "Narrow-band UVB
phototherapy shows potential as a novel therapeutic option for patients with stage I mycosis
fungoides ??" The article goes on to state that " ??three such patients each showed greater
than 70% improvement after a mean of 18 narrow-band treatments, with clinical remission
achieved after a mean of 30 treatments, or 14.5 weeks" which is quicker than broad-band
UVB. The same article also presents information on positive results in Vitiligo and Atopic
Dermatitis using Narrow Band UVB phototherapy therapy.

Phototherapy is the process of treating the human body with various wavelengths of light
such as laser, ultra violet or infra red. Different wavelengths and intensities offer medically
proven treatment for chronic skin conditions.

Sumber : http://www.beatacne.org/phototherapy.htm

Mechanisms of ultraviolet UVB and UVA phototherapy.

Krutmann J, Morita A.

Clinical and Experimental photodermatology, Department of Dermatology, Heinrich-Heine-

University, Dusseldorf, Germany.

Ultraviolet (UV) radiation has been used for decades with great success and at a constantly
increasing rate in the management of skin diseases, becoming an essential part of modern
dermatologic therapy (Krutmann et al, 1999). For phototherapy, irradiation devices emitting
either predominantly middle wave UV (UVB, 290-315 nm) or long wave UV (UVA, 315-400
nm) radiation are employed. In former years, patients were treated with broad-band UVB,
broad-band UVA, or combination regimens. Broad-band UV phototherapy, however, is being
replaced more frequently by the use of irradiation devices that allow treatment of patients'
skin with selected emission spectra. Two such modalities which have their origin in European
photodermatology are 311 nm UVB phototherapy (which uses long-wave UVB radiation
above 300 nm rather than broadband UVB) and high-dose UVA1 therapy (which selective
employs long-wave UVA radiation above 340 nm). In Europe, 311 nm UVB phototherapy has
almost replaced classical broad-band UVB phototherapy and has significantly improved
therapeutic efficacy and safety of UVB phototherapy (van Welden et al, 1988; Krutmann et
al, 1999). The constantly increasing use of UVA-1 phototherapy has not only improved UVA
phototherapy for established indications such as atopic dermatitis (Krutmann et al, 1992a,
1998; Krutmann, 1996), but has also provided dermatologists with the opportunity to
successfully treat previously untraceable skin diseases, e.g., connective tissue diseases (Stege
et al, 1997; Krutmann, 1997). These clinical developments have stimulated studies about the
mechanisms by which UVB and UVA phototherapy work. The knowledge obtained from this
work is an indispensable prerequisite to make treatment decisions on a rationale rather than
an empirical basis. Modern dermatologic phototherapy has started to profit from this
knowledge, and it is very likely that this development will continue and provide
dermatologists with improved phototherapeutic modalities and regimens for established and
new indications. This review aims to provide an overview about current concepts of the mode
of action of dermatologic phototherapy. Special emphasis will be given on studies that have
identified previously unrecognized immunosuppressive/anti-inflammatory principles of UV
phototherapy.

PMID: 10537012 [pubMed - indexed for MEDLINE]

Sumber : http://www.beatacne.org/uv-phototherapy.htm

Taking psoriasis treatment to the patient: development of a home TL-01 ultraviolet B

phototherapy service.
Br J Dermatol. 2002 Nov;147(5):957-65.

Cameron H, Yule S, Moseley H, Dawe RS, Ferguson J.

A study into home phototherapy treatment for psoriasis.

Photobiology Unit, Department of Dermatology, University of Dundee, Ninewells Hospital

and Medical School, Dundee DD1 9SY, U.K.

BACKGROUND: While most patients requiring phototherapy can attend for hospital-based
out-patient ultraviolet (UV) B therapy, a significant number cannot attend because of
geographical, work, economic and other reasons. OBJECTIVES: To determine whether there
was a need for home phototherapy in the Tayside area and, if so, to establish protocols and
then to assess if such a service would be workable. METHODS: patients referred from
dermatology out-patient clinics in Tayside for narrow-band UVB (TL-01) phototherapy
completed a pilot questionnaire that was followed by a two-phase project. In phase 1, patients
with psoriasis were trained to use the home phototherapy equipment (HopE) within the
hospital department under nursing supervision while a teaching package and protocols were
developed. In phase 2, home phototherapy was made available for patient use in the
community, supported by a specialist home phototherapy nurse. Waldmann UV100 home
therapy units were used, with accurate dosimetry. Detailed treatment records were kept and
questionnaires were used to assess acceptability and costs of therapy.

RESULTS: Fifty-two pilot questionnaires were completed. Forty-two per cent of respondents
found hospital phototherapy inconvenient and 75% felt phototherapy at home would be
helpful. In phase 1, seven of 10 patients trained to use the HopE completed therapy with the
HopE unit alone, reaching minimal residual activity (MRA) or clearance in a median of 18
exposures (median dose 10.38 J cm-2). In phase 2, 32 courses of home phototherapy were
given to 30 patients. Of 23 with psoriasis, 18 reached clearance or MRA in a median of 22.5
exposures (median dose 9.84 J cm-2). Although self-reported erythema rates appeared higher
than expected, all post-treatment questionnaire respondents would choose home phototherapy
over hospital therapy if required in the future. CONCLUSIONS: UVB (TL-01) home
phototherapy is a useful practical development that has fulfilled a need in our catchment area.
Where appropriate training and support teams are available it appears to be similar in
effectiveness to hospital therapy, to be safe and to be cost-effective for patients.

pMID: 12410707 [pubMed - indexed for MEDLINE]

Home phototherapy: report on a workshop of the British photodermatology Group,

December 1996.

Br J Dermatol. 1999 Feb;140(2):195-9. Related Articles, Links

Sarkany Rp, Anstey A, Diffey BL, Jobling R, Langmack K, McGregor JM, Moseley H,
Murphy GM, Rhodes LE, Norris PG.

Department of Dermatology, Addenbrooke's Hospital, Cambridge, UK. phototherapy is a

popular and effective treatment for many patients with skin diseases. However, repeated
journeys to hospital for phototherapy can be inconvenient and expensive. If it were available,
many patients might prefer home-based phototherapy as long as it was safe and effective.
Indeed, many psoriasis patients already self-treat with ultraviolet A sun beds at home. This
report represents a consensus view from a British photo dermatology Group workshop held in
December 1996, the purpose of which was to examine the potential role of home-based
phototherapy in dermatological practice. We conclude that home-based therapy represents a
suboptimal treatment with greater attendant risks than phototherapy in a hospital
environment. The level of medical supervision of the home treatment is crucial to its safety
and effectiveness. Until further studies are forthcoming, home phototherapy should be largely
restricted to those with overwhelming difficulties in attending hospital.

PMID: 10733266 [pubMed - indexed for MEDLINE]

An assessment of potential problems of home phototherapy treatment of psoriasis.

Cutis. 1996 Jul;58(1):71-3.

Feldman SR, Clark A, Reboussin DM, Fleischer AB Jr.

Department of Dermatology, Bowman Gray School of Medicine of Wake Forest University,

Winston-Salem, North Carolina 27157-1071, USA.

Very little has been reported about how patients use home ultraviolet B (UVB) phototherapy.
A survey of thirty-one patients who were prescribed a home UVB phototherapy unit to treat
psoriasis was performed as a pilot study of home UVB phototherapy usage; twenty-two
patients responded. Generally, respondents reported home UVB phototherapy to be very
helpful for their psoriasis. We conclude that home UVB is an effective and appropriate
treatment for many patients with psoriasis, but screening and education of candidates for
home UVB phototherapy is important to ensure compliance with the treatment program.

PMID: 8823554 [pubMed - indexed for MEDLINE]

Phototherapy at home is the perfect solution for chronic skin disease management. Home
phototherapy provides convenient, better results and saving in both time and money.

Sumber : http://www.beatacne.org/home-phototherapy.htm

UV phototherapy light technical information

Phototherapy is the process of treating the human body with various wavelengths of light
such as laser, ultra violet or infra red. Different wavelengths and intensities offer medically
proven treatment for chronic skin conditions.
Dermalight products solve the problems of over-exposure to ultraviolet light by maximizing
the delivery of narrow-band UVB radiation (in the 311-312nm range, the most beneficial
component of natural sunlight) while minimizing exposure to superfluous UV. This allows
patients to receive phototherapy treatments with less risk of severe burning or pathogenic
exposure to more harmful wide band radiation ranges. UVB narrow-band also avoids the
adverse side effects of the psoralen drugs used in conventional PUVA therapy, since UVB
treatment requires no supplemental drugs.) These therapeutic benefits have made the
Dermalight products the fastest-selling phototherapy units in Australia, the UK, Europe and
now America. UVB treatment is around 83% successful and narrow band UVB treatment is
around 90% successful, or 95% when used in conjunction with a coal tar product. We suggest
that you personally ascertain if you respond to UV treatment via consultation with your
doctor, modest exposure to the sun or have already undertaken a successful course of UV
treatment.

Clinical studies show the peak therapeutic effectiveness of UVB to be within the 295-313nm
range but wavelengths below 300nm are more likely to cause erythema or severe burning and
increase the risk of skin cancer. Narrow band UVB is in the 311-312nm range, and therefore
does not emit the more dangerous wide spectrum that includes wavelengths of 280-300nm
and above 330nm.

Because wavelengths below 300nm are eliminated UVB narrow band therapy times can be
increased more safely, so patients can derive the maximum benefit from phototherapy. The
increase effectiveness permits more aggressive treatment regimens, resulting in a shorter
course of treatment. Extensive research confirms that patients not only avoid the danger of
serious burning from sub-erthemal exposure, they may also enjoy longer remission periods
after treatment.

Remission periods are similar to those with PUVA therapy and markedly superior to road-
band UVB treatment. Studies show 38-40 percent of narrow band patients require no
additional therapy for at least 12 months.

Narrow Band UVB light is at a wave length of 311nm, most other products emit the older,
more dangerous radiation in the wide band spectrum. Narrow band UVB is much safer than
full spectrum UVB, and the output is reduced by well over 97%. Narrow band UVB is the
exact wave length that psoriasis responds to best. Why bombard your skin with unneeded
light radiation? Even many UVB products in hospitals are older style, full UVB spectrum
products as they are often many years old. If you imagine sun exposure to natural sunlight is
equal to 100% UV radiation exposure, using a narrow band UV light is roughly 1% UV
radiation exposure (powerful and targeted treatment.)
All our products use premium medical quality globes and the best possible component that
are available today. We offer a full range of products that provide combined wide band UVA
& UVB or exclusively Narrow Band UVB 311nm.

UVB or UVA ??*

Natural sun light is made up of two different wavelengths of ultraviolet (UV) light: UVA and
UVB. In contrast, sun beds usually contain high levels of mainly UVA rays. Since the
common misconception is that UVB light can burn and damage skin, it is a FALSE
understanding that UVA tanning beds and salons are safe. In fact, UVA light penetrates much
deeper into the skin that than UVB rays, damaging elastic fibbers that keep the skin supple.
UVA rays also make the skin more vulnerable to the effects of UVB, so using a sun bed
means that you'll be more likely to burn when you're exposed to natural sunlight for the next
7-10 days. UVB light can burn skin from over exposure (just like natural sunlight can) but it
is the SAFEST part of the UV light spectrum and clinically proven as an effective treatment
for many skin conditions. Used in moderation and according to an approved treatment
program UVB is a highly effective and SAFE treatment as recommended by a leading
international psoriasis foundation. *Source Top Sante Magazine August 2002.
what about skin cancers?

The risk for psoriasis patients on a life long UVB treatment will probably be of the same
order of magnitude as for outdoor workers. In comparison with other every day risks, the
risk of dying from a skin cancer seems to be negligible. Regular check-ups by a
dermatologist can reduce this risk close to zero.

It would be unethical to say there is absolutely no risk of skin cancer. Most treatments today
have some form of side effect, even the common aspirin and pain killers can have drastic
affects such as causing liver damage, although very rare. The possibility of side effects are
minimized by following the recommended guidelines. The possible side effects need to be
considered before undertaking any form of treatment. It is important to know that there is no
single proven case of narrow band UV phototherapy causing skin cancer, although it is
known UV can cause skin cancer. We have several independent documents in our web forum
that discuss cancer involved with UV. Furthermore, skin cancers can appear any place on the
body, even the soles of the feet and arm pits that have obviously not been exposed to UV
radiation, therefore it is highly likely that some people are simply predisposed to skin cancer.

Sumber : http://www.beatacne.org/uvb-technical.htm
Experience with UVB phototherapy in children

pediatr Dermatol. 1996 Sep-Oct;13(5):406-9.

Tay YK, Morelli JG, Weston WL.

Department of Pediatric Dermatology, University of Colorado Health Sciences Center,

Denver 80262, USA.

Twenty children age 14 months to 12 years with photo responsive dermatosis were treated
with ultraviolet B (UVB) phototherapy over four years. Ten children had psoriasis, five had
pityriasis lichenoids, and five had atopic dermatitis. All received short courses (average 34
treatments) of phototherapy with either no maintenance or short maintenance. Treatment was
effective and well tolerated in most patients, and no serious side effects were seen. Patients
with psoriasis and pityriasis lichenoides cleared completely. No patient with atopic dermatitis
cleared completely, but all were moderately improved, with reduction of the extent of eczema
and decreased pruritus. It appears that UVB phototherapy is a valuable and safe therapeutic
option for selected children who do not respond to other treatments.

PMID: 8893243 [pubMed - indexed for MEDLINE]

We conclude that narrowband UVB phototherapy is a useful and well-tolerated treatment for
children with severe or intractable inflammatory skin disease, but concerns remain regarding
long-term side-effects.

Sumber : http://www.beatacne.org/phototherapy-children.htm
Dermaray Full Body UVB Phototherapy

Dermaray Canopy 10 (1000watt) is fitted with 10 genuine original Philips Narrow Band
UVB medical bulbs. The system is lightweight and moves easily on the wheels supplied. Not
to be confused with tanning salon machines that are usually 100% UVA or at best 2% UVB in
the form of 98% UVA + 2%UVB. Tanning salon systems should not be used in the treatment
of psoriasis or vitiligo and are no substitute for narrow band UVB medical treatment.
Dermaray Canopy 10 has an innovative cooling system combined with digital inline timer
that will stop treatment after the exact therapy time has expired. Dermaray Canopy 10 can be
used conveniently over a bed, or used in the standing upright position. Our range of full body
phototherapy equipment is very versatile offering convenient horizontal or vertical treatment.
Ideal for home, office or clinical use. Full body treatment is concluded in 2.5 ~ 3.5 minutes
per side such as front and back. A full body treatment is completed in 5 ~ 7 minutes.

Available in either 110v or 220v native configuration, no messy external step up or step down
transformers required. Dermaray Canopy 10 has CE approval. Dermaray Canopy 10 UVB
Phototherapy can be sent worldwide without the need of a prescription. We can provide
delivery or you can organise your own freight service.
Dermaray Canopy 24 (2400watt) is fitted with 24 genuine original Philips Narrow Band
UVB medical bulbs. Not to be confused with tanning salon machines that are usually 100%
UVA or at best 2% UVB in the form of 98% UVA + 2%UVB. Tanning salon systems should
not be used in the treatment of psoriasis or vitiligo and are no substitute for narrow band
UVB medical treatment. Dermaray Canopy 24 has an innovative cooling system combined
with digital inline timer that will stop treatment after the exact therapy time has expired. Full
body treatment is concluded in only 2 ~ 3 minutes.

Available in either 110v or 220v native configuration, no messy external step up or step down
transformers required. Dermaray Canopy 24 has CE approval. Dermaray Canopy 24 UVB
Phototherapy can be sent worldwide without the need of a prescription. We can provide
delivery or you can organise your own freight service.
Sumber : http://www.beatacne.org/fullbody-uvb-phototherapy.htm
Beat hair loss with the Dermaray Hair Loss Laser Comb 100

Our Dermaray Laser is the latest development in hair loss laser comb technology. The
Dermaray Laser offers more power, at 100mW it is 5 to 20 times the power of other hair loss
lasers on the market. The unit combines this power with unique and advanced safety features.
We include a universal power adapter which with the correct plug connector allows the unit
to operating in differant countries with differing voltages. The universal adapter also doubles
as a battery chargercombining to deliver the convenience of battery operation.

It includes many unique safety features found only in the Dermaray Laser. Dermaray Laser
makes other laser combs seem old and obsolete.

Dermaray Laser features

 2 year factory warranty

 100mW configuration with 5 x 20mW @ 660nm (computer controlled)
 Battery operation with inbuilt charger
 Universal 110 ~ 260v battery charger and power supply
 Unique safety features that include proximity detection, session management,
frequency alert, computer calculated and computer managed exposure programs.
 Comes standard with 2 sets of safety goggles, small and large type
 World wide delivery by express courier to your door
 No doctor's letter or prescription required
 Designed and manufactured in Australia under ISO9000 standards
 Dermary Hair regrowth Laser Laser User Manual
 Dermary Laser Quickstart Guide (always read the User Guide)

Dermaray Hair Loss Laser tutorial videos

All of the videos on Beatpsoriasis are available on the Dermaray YouTube Channel here.

http://www.youtube.com/watch?v=-Kmoz10sj2g&feature=player_embedded

http://www.youtube.com/watch?v=o51xWohffMk&feature=player_embedded

Sumber : http://www.beatacne.org/dermaray-laser.htm
Dermaray UV Phototherapy Lamp

The Dermaray UV is the latest development in home UV phototherapy. It is equally suitable

for individuals at home, the doctors clinic or a hospital providing out patient equipment. No
longer is the home phototherapy patient required to manually and awkwardly both calculate
and manage each and every treatment of a program that may last many months. Dermaray
UV takes the guess work out of home UV phototherapy for individuals managing each and
every treatment. In a hospital or doctors practice the Dermaray UV computer can be
programmed with up to 10 patients each with as many as 32 treatment areas. Add to this
Dermaray UV is the ONLY battery operated home UV phototherapy system and comes with a
universal power adapter and battery charger.

It includes many unique safety features found only in Dermaray UV. Dermaray UV makes
other UV systems seem old and obsolete. Dermaray UV has been designed by users of home
phototherapy equipment and operates the way that patients want.

In professional settings the onboard computer allows doctors to program treatment plans for
patients and to service multiple patients

Dermaray UV features

 2 year factory warranty

 standard with Philips Narrow Band UVB NB311 medical bulb
 Battery operation with inbuilt charger
 Universal 110 ~ 260v battery charger and power supply
 Unique safety features that include proximity detection, session management,
frequency alert, computer calculated and computer managed exposure programs.
 Comes standard with 2 sets of safety goggles, small and large type
 Available with UVA or WB-UVB for a nominal extra cost
 World wide delivery by express courier to your door
 No doctor's letter or prescription required
  Designed and manufactured in Australia under ISO9000 standards
 Dermary UV User Manual
 Dermary UV Quickstart guide (always read the user manual first)

Dermaray UVB treatment tutorial videos

http://www.youtube.com/watch?v=o51xWohffMk&feature=player_embedded

http://www.youtube.com/watch?v=QeVLrJobRVw&feature=player_embedded

Sumber : http://www.beatacne.org/dermaray-uv.htm

Dermalight 80 UV treatment.

Beat Psoriasis has ceased distribution of the dermalight80, we now off the Dermaray UV
product We now only provide warranty support for customers who have purchased a
dermalight80 from Beat Psoriasis. You may still purchase replacement globes from our online
store

The dermalight80 (sometimes mistaken for the Handisol in the USA) is the original hand held
UV phototherapy device. The dermalight80 is a compact and versatile UV home
phototherapy unit. The dermalight80 was also our most popular product until the introduction
of the Dermaray UV.

The Dermalight80 was supplied as standard with UVB-Narrow Band 311nm bulbs but was
also available with either UVA or UVB at no extra cost (our competitors charge up to $10
extra to change bulb types.) The Dermalight80 is easy to use and also ideal for in-home
phototherapy. To get an idea of the treatment program, you can view the instruction manual
for the Dermalight80 here online. The standard Narrow Band UVB-311 Dernalight80 is best
suited for psoriasis, vitiligo, eczema and similar conditions.

 FREE 2 year warranty, DOUBLE the warranty offered by US suppliers and no

doctor's prescription or letter required Competitions
 no prescription or doctor's letter required
 express air courier delivery world wide. Competitions
  best pricing guaranteed, if you happen to find a better price, please bring it to our
attention and we will happily better any total price Competitions

110v (USA, Canada, Japan etc) and 220-240v (UK, Europe, Australia & New Zealand etc)
units are both readily available - we know which product voltage suits your country and
location. The Dermalight80 includes a 2 year warranty and 30 days on globes.

ermalight80 is a light weight, ergonomic, hand held UV phototherapy lamp. Perfect for
treatment of Psoriasis, Vitiligo, Dermatitis, Acne or Alopecia hair loss.

Dermalight80 features

 free power transformer supplied either 110v or 220v

 2 year manufacturer's warranty included (double that offered by some suppliers)
 no prescription or doctor's letter required to order
 no extra cost if you swap to UVA or WB-UVB bulbs treats all parts of the body
including the face and scalp
 we know which voltage suites your country and location Phillips UVB NB-311
narrow band bulbs are standard
 comb attachment included for scalp treatment
 uniyt instructions, timer and UV safety goggles include
 30 day warranty on bulbs
 bulb life approx 400 hours or several years
http://www.beatacne.org/dermalight80.htm

Aculas hair loss laser LLLT therapy, hand held and

helmets.
Beat Psoriasis has ceased offering the Aculas 100mW hair loss laser system. We no longer
have any new units.

We do continue to provide warranty support for customer who purchased their Aculas Laser
from us and have evidence of purchase.
The100mW configuration and 5 20mW individual laser modules digitally scattered, no
plastic mirrors or plastic fibre optics.

Ever wondered why most manufacturers do not mention how strong their laser power is?

Some brands sound impressive, but may only have a single 1mW laser and an array of cheap
and low powered LEDs (light emitting diodes) there are NOT laser devices..

Although some competitors are more interested in fancy designs, extensive marketing and
advertising, we have concentrated on designing, developing and delivering the most powerful
and effective home LLLT device available today.

See how the unique Dermaray design offers more direct laser power and more actual laser
modules than any other brand laser comb. While there are other brands and various home
made products, none offer electrically safe (CE approved) power supplies nor use genuine
laser diodes. Many products claim to contain laser diodes but actually contain Light Emitting
Diodes or LEDs. .

From some suppliers, you will hear fantastic stories about NASA experiments, you will hear claims of
being the very best product available and misleading comments about other product designs. We
simply give you the most powerful computer controlled laser available, without the use of lens, LEDs,
mirrors or other gimmicks. Ever wonder why most brands do not mention their LASER power output
or laser power DENSITY? Infrared diodes are NOT laser modules.

Aculas hair loss laser specifications

 free universal power supply can be used anywhere

 12 month manufacturer's warranty included
  5 x 20mW laser modules, total 100mW laser output
 laser wavelength 660nm (see other configurations available below)
 computer microprocessor controlled system
 large, user friendly blue back lit LCD screen
 automatic shut off timer
 default programming set to 15 minutes
 user friendly musical tones for end session and fault alert
 self calibration and diagnostic at activation
 direct laser power (no mirrors, no lens, no batteries)
 dimensions in mm = 127.3 (L) x 190.8 (W) x 44.7 (H)
 dimensions in inch = 5.01 (L) x 7.51 (W) x 1.76 (H)
 weight of METAL hand unit only 0.25 Kg
 EMI Certifications; FCC Class B, CISPR 22 Class B
 laser safety class European IIIb, USA 3R
 certifications; UL2601-1, CBIEC 60601-1, TUBEN60601-1
 no prescription or doctor's letter required to order
 Click here for technical details of the Aculas hair loss laser design
 Will hair loss laser therapy work for me?
 Can be used safely in conjunction with our Hair Loss Treatment Kits here
 Why 5mW modules and 25mW total is insufficient

Sumber : http://www.beatacne.org/aculas.htm
Sunetics personal hair loss laser brush
Thank you for your time and considering to purchase you phototherapy devices from
BEATPSORIASIS.COM. We are committed to providing the best possible price and delivery
for clients where ever you are around the world.

BEATPSORIASIS.COM have withdrawn the Sunetics Laser Hair Bush and replaced it with
the new and revolutionary Dermaray Laser Comb.

We continue to offer warranty support to customer who purchased their units from us.

The Sunetics Laser Hair Brush (better than any Laser Comb)
was designed in the United States by Dr. Charles Maricle and
is manufactured under strict quality assurance guidelines.
The Sunetics Laser Hair Brush has patents pending in the US
and around the world. Sunetics International started in the
hair enhancement industry with its Model "E" Clinical Laser. This laser was incredibly
successful and was quickly sold to clinics around the U.S. and abroad. The Sunetics Laser
Hair Brush was developed to meet the need of clients who could not attend or could not
afford treatments at local clinics.

Achieve Thicker, Fuller, Shinier and Healthier Looking Hair. The Laser Hair Therapy
technology has been used aboard for years to achieve Thicker, Fuller, Shinier and Healthier
Looking Hair.

Cordless & Convenient. Use the Sunetics Laser Hair Brush any time any place. The
Sunetics Laser Hair Brush will operate for 17 hours on a single charge. This will last for
months of recommended usage.

Completely Safe with NO SIDE EFFECTS. The Sunetics Laser Hair Brush uses Low Level
Laser Light, there are No Chemicals involved, just the power of Low Level Laser Light.
Easy to Use. Use the Sunetics Laser Hair Brush for 5 to 10 minutes, three times per week for
great results.

Worldwide Delivery Available. We will gladly deliver your Sunetics Laser Hair Brush by
express world wide courier delivery at a discounted rate.

Economical Price. Other units costs hundreds of dollar more, we design and manufacture the
Sunetics Laser Hair Brush, so you get the best pricing.

Excellent Customer Support. We are available to provide you advice on the best way to use
your brush.

Complies with all applicable U.S. Laser safety standards. The Sunetics Laser Hair Brush
is specifically designed to be used in your home, in a safe and private environment.

Before After
Sumber : http://www.beatacne.org/sunetics.htm